Anti-gliadin antibody IgA
EstablishedAnti-gliadin IgA is an outdated celiac disease marker superseded by tTG-IgA testing.
This older test for celiac disease is no longer considered reliable. Newer, more accurate blood tests (like tTG-IgA) have replaced it, so a result from this older test alone shouldn't be used to diagnose celiac disease.
Anti-gliadin IgA antibodies target gliadin, a component of gluten, and were historically used to screen for celiac disease, an autoimmune reaction to gluten damaging the small intestine.
Current professional guidance (AACC, ACG) states anti-gliadin antibody testing has low diagnostic accuracy and is no longer recommended for detecting celiac disease, having been superseded by more accurate tests.
Anti-tissue transglutaminase (tTG) IgA is now the recommended first-line test for suspected celiac disease in patients over age 2, with deamidated gliadin peptide (DGP) antibodies used as an alternative, particularly in young children or IgA-deficient patients.
Given its outdated status, a positive anti-gliadin IgA alone should not be relied upon for a celiac diagnosis; confirmatory tTG-IgA or DGP testing (and possibly biopsy) is warranted before starting a gluten-free diet.
Low diagnostic accuracy per current guidelines; should not be used as a stand-alone celiac test today.
- AACC. (2023). Anti-Gliadin Antibody Assay — Optimal Testing Guide.
- AAFP. (2017). Comparative Accuracy of Diagnostic Tests for Celiac Disease.